GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: This chemical structure was obtained from WHO Proposed list 125. It is recorded as a tyrosine kinase inhibitor with potential antineoplastic activity. As of August 2021, it appears to be an undisclosed agent, with no definitive molecular target, no presence in online chemistry resources, and the term 'gemnelatinib' does not retrieve any hits from a web search.
|
|
Bioactivity Comments |
We have been unable to find any pharmacological or biological data for gemnelatinib. |